Contributions of Eosinophils to Human Health and Disease.

The human eosinophil has long been thought to favorably influence innate mucosal immunity but at times has also been incriminated in disease pathophysiology. Research into eosinophil biology has uncovered a number of interesting contributions by eosinophils to health and disease. However, it appears that not all eosinophils from all species are created equal. It remains unclear, for example, exactly how having eosinophils benefits the human host when helminth infections in the developed world have become scarce. This review focuses on our current state of knowledge as it relates to human eosinophils. When information is lacking, we discuss lessons learned from mouse studies that may or may not directly apply to human biology and disease. It is an exciting time to be an "eosinophilosopher" because the use of biologic agents that selectively target eosinophils provides an unprecedented opportunity to define the contribution of this cell to eosinophil-associated human diseases.

[1]  R. Fitzgerald,et al.  Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  A. Zwinderman,et al.  Anti‐IL‐5 in Mild Asthma Alters Rhinovirus‐induced Macrophage, B‐Cell, and Neutrophil Responses (MATERIAL). A Placebo‐controlled, Double‐Blind Study , 2019, American journal of respiratory and critical care medicine.

[3]  S. Fujieda,et al.  Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis , 2019, Front. Immunol..

[4]  Kelley E. Capocelli,et al.  The 1‐Hour Esophageal String Test: A Non‐Endoscopic Minimally Invasive Test to Accurately Detect Disease Activity in Eosinophilic Esophagitis: 935 , 2019, Journal of Allergy and Clinical Immunology.

[5]  V. Gaponenko,et al.  Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness , 2019, The Journal of allergy and clinical immunology.

[6]  J. Brennan,et al.  Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip , 2019, Allergy.

[7]  W. Busse,et al.  Anti–IL‐5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison , 2019, The Journal of allergy and clinical immunology.

[8]  Ascp,et al.  Siglec-8 in eosinophilic disorders: receptor expression and targeting using chimeric antibodies , 2019 .

[9]  S. Fujieda,et al.  Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death. , 2018, Blood.

[10]  J. Utikal,et al.  Opposing roles of eosinophils in cancer , 2018, Cancer Immunology, Immunotherapy.

[11]  P. Khoury,et al.  Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options. , 2018, The journal of allergy and clinical immunology. In practice.

[12]  M. Fay,et al.  Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome. , 2018, The journal of allergy and clinical immunology. In practice.

[13]  P. Zeitlin,et al.  Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial , 2018, Journal of asthma and allergy.

[14]  M. Fay,et al.  Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. , 2018, Blood.

[15]  A. Straumann,et al.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  C. Brightling,et al.  In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients , 2018, The Journal of allergy and clinical immunology.

[17]  I. Hirano,et al.  Biological therapies for eosinophilic gastrointestinal diseases , 2018, The Journal of allergy and clinical immunology.

[18]  P. Weller,et al.  Contemporary understanding of the secretory granules in human eosinophils , 2018, Journal of leukocyte biology.

[19]  H. Simon,et al.  Revisiting the NIH Taskforce on the Research needs of Eosinophil‐Associated Diseases (RE‐TREAD) , 2018, Journal of leukocyte biology.

[20]  James J. Lee,et al.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease , 2018, Journal of leukocyte biology.

[21]  K. Rabe,et al.  Efficacy and Safety of Dupilumab in Glucocorticoid‐Dependent Severe Asthma , 2018, The New England journal of medicine.

[22]  D. Allman,et al.  No strict requirement for eosinophils for bone marrow plasma cell survival , 2018, European journal of immunology.

[23]  H. Jäck,et al.  Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow , 2018, European journal of immunology.

[24]  K. Bennett,et al.  CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils , 2018, Front. Immunol..

[25]  B. Bochner The eosinophil: For better or worse, in sickness and in health. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[26]  C. Bebbington,et al.  A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Phase 1 Study of AK002, a Novel Siglec-8 Selective Monoclonal Antibody, in Healthy Subjects , 2018 .

[27]  G. Marone,et al.  Eosinophils: The unsung heroes in cancer? , 2018, Oncoimmunology.

[28]  B. Chawes,et al.  Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis , 2018, European clinical respiratory journal.

[29]  P. Khoury,et al.  Clinical and Biological Markers in Hypereosinophilic Syndromes , 2017, Front. Med..

[30]  F. Antonicelli,et al.  Biomarkers related to bullous pemphigoid activity and outcome , 2017, Experimental dermatology.

[31]  P. Weller,et al.  Functions of tissue-resident eosinophils , 2017, Nature Reviews Immunology.

[32]  T. Myers,et al.  Dysregulation of interleukin 5 expression in familial eosinophilia , 2017, Allergy.

[33]  P. Fulkerson Transcription Factors in Eosinophil Development and As Therapeutic Targets , 2017, Front. Med..

[34]  I. Bachelet,et al.  CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production , 2017, Scientific Reports.

[35]  T. Marichal,et al.  Homeostatic Eosinophils: Characteristics and Functions , 2017, Front. Med..

[36]  A. Klion Recent advances in understanding eosinophil biology , 2017, F1000Research.

[37]  P. Thomas,et al.  Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus , 2017, The Journal of Immunology.

[38]  Sara R. Selitsky,et al.  A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults , 2017, Clinical and translational gastroenterology.

[39]  C. Porsbjerg,et al.  Clinical characteristics of eosinophilic asthma exacerbations , 2016, Respirology.

[40]  J. Appleton,et al.  Eosinophils in Helminth Infection: Defenders and Dupes. , 2016, Trends in parasitology.

[41]  A. Ghaemmaghami,et al.  Effective antigen presentation to helper T cells by human eosinophils , 2016, Immunology.

[42]  W. Muller Transendothelial migration: unifying principles from the endothelial perspective , 2016, Immunological reviews.

[43]  J. Rinn,et al.  The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan , 2016, Nature.

[44]  W. Petri,et al.  Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection. , 2016, Cell reports.

[45]  M. Fay,et al.  Clinical features predict responsiveness to imatinib in platelet‐derived growth factor receptor‐alpha‐negative hypereosinophilic syndrome , 2016, Allergy.

[46]  M. Svensson-Frej,et al.  Eosinophils may play regionally disparate roles in influencing IgA+ plasma cell numbers during large and small intestinal inflammation , 2016, BMC Immunology.

[47]  D. Dorward,et al.  Key mechanisms governing resolution of lung inflammation , 2016, Seminars in Immunopathology.

[48]  M. Westphall,et al.  The Peripheral Blood Eosinophil Proteome. , 2016, Journal of proteome research.

[49]  P. Kuna,et al.  Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma , 2016, BMJ Open.

[50]  Shiori Yamamoto,et al.  Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes. , 2016, The Journal of allergy and clinical immunology.

[51]  Manna Zhang,et al.  Eosinophils Reduce Chronic Inflammation in Adipose Tissue by Secreting Th2 Cytokines and Promoting M2 Macrophages Polarization , 2015, International journal of endocrinology.

[52]  B. Bochner Novel Therapies for Eosinophilic Disorders. , 2015, Immunology and allergy clinics of North America.

[53]  J. Woosley,et al.  Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study , 2015, The American Journal of Gastroenterology.

[54]  M. Raffeld,et al.  Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder , 2015, Haematologica.

[55]  R. Raskin,et al.  Reptilian Eosinophils: Beauty and Diversity by Light Microscopy. , 2015, Veterinary clinical pathology.

[56]  Eh Lee,et al.  IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production , 2014, Mucosal Immunology.

[57]  M. Camilleri,et al.  Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[58]  Lisa J. Martin,et al.  Food , drug , insect sting allergy , and anaphylaxis Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis , 2022 .

[59]  T. Neri,et al.  Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art , 2014, Front. Immunol..

[60]  M. Telen,et al.  Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia , 2014, PloS one.

[61]  D. Broide,et al.  Smad3-Deficient Mice Have Reduced Esophageal Fibrosis and Angiogenesis in a Model of Egg-Induced Eosinophilic Esophagitis , 2014, Journal of pediatric gastroenterology and nutrition.

[62]  R. Palmiter,et al.  Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat , 2014, Cell.

[63]  K. Acharya,et al.  Eosinophil Granule Proteins: Form and Function , 2014, The Journal of Biological Chemistry.

[64]  M. Raffeld,et al.  The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. , 2014, The Journal of allergy and clinical immunology.

[65]  C. Berek,et al.  Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. , 2014, Immunity.

[66]  James J. Lee,et al.  Eosinophils Regulate Peripheral B Cell Numbers in Both Mice and Humans , 2014, The Journal of Immunology.

[67]  C. Persson,et al.  Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma. , 2014, American journal of respiratory and critical care medicine.

[68]  James J. Lee,et al.  PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Activated mouse eosinophils protect against lethal respiratory virus infection , 2015 .

[69]  E. Chilvers,et al.  Measurement of eosinophil kinetics in healthy volunteers. , 2014, Methods in molecular biology.

[70]  E. King,et al.  Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. , 2013, Gastroenterology.

[71]  James J. Lee,et al.  Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia , 2013, Allergy.

[72]  James J. Lee,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Expression of the secondary granule proteins major basic protein 1 ( MBP-1 ) and eosinophil peroxidase ( EPX ) is required for eosinophilopoiesis in mice , 2013 .

[73]  James J. Lee,et al.  The consequences of not having eosinophils , 2013, Allergy.

[74]  John A. Besse,et al.  Targeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth , 2013, PloS one.

[75]  R. Locksley,et al.  Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.

[76]  John A. Besse,et al.  miR-223 Deficiency Increases Eosinophil Progenitor Proliferation , 2013, The Journal of Immunology.

[77]  K. Dyer,et al.  Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.

[78]  James J. Lee,et al.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". , 2012, The Journal of allergy and clinical immunology.

[79]  W. Busse,et al.  Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). , 2012, The Journal of allergy and clinical immunology.

[80]  T. Haferlach,et al.  Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. , 2012, The Journal of allergy and clinical immunology.

[81]  D. Fleischer,et al.  The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis , 2012, Gut.

[82]  N. Bhattacharyya,et al.  Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. , 2012, Blood.

[83]  S. Wenzel,et al.  Asthma outcomes: biomarkers. , 2012, The Journal of allergy and clinical immunology.

[84]  M. Fay,et al.  IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis. , 2011, The Journal of allergy and clinical immunology.

[85]  A. Varki,et al.  Siglec-F Inhibition Reduces Esophageal Eosinophilia and Angiogenesis in a Mouse Model of Eosinophilic Esophagitis , 2011, Journal of pediatric gastroenterology and nutrition.

[86]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[87]  C. Berek,et al.  Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.

[88]  D. Traver,et al.  Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants. , 2010, Blood.

[89]  W. Busse,et al.  Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. , 2010, The Journal of allergy and clinical immunology.

[90]  O. Yang,et al.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. , 2010, Clinical immunology.

[91]  James J. Lee,et al.  Eosinophils in health and disease: the LIAR hypothesis , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[92]  J. Sheikh,et al.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. , 2009, The Journal of allergy and clinical immunology.

[93]  R. Egan,et al.  The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases , 2009, Journal of Pharmacology and Experimental Therapeutics.

[94]  L. Kremer,et al.  TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. , 2009, Blood.

[95]  K. Akashi,et al.  Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor , 2009, The Journal of experimental medicine.

[96]  A. Sharma,et al.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation. , 2009, Blood.

[97]  A. Straumann,et al.  Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.

[98]  D. Broide,et al.  Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. , 2008, Current molecular medicine.

[99]  J. Parkin,et al.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab. , 2008, The New England journal of medicine.

[100]  I. Ghiran,et al.  Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells1 , 2007, The Journal of Immunology.

[101]  S. Gordon,et al.  EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor , 2007, European journal of immunology.

[102]  M. Goldman,et al.  Lymphocytic variant hypereosinophilic syndromes. , 2007, Immunology and allergy clinics of North America.

[103]  R. Weiss,et al.  EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. , 2007, Blood.

[104]  S. Phipps,et al.  Eosinophil trafficking in allergy and asthma. , 2007, The Journal of allergy and clinical immunology.

[105]  Mitchell Cohen,et al.  Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[106]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[107]  J. Varga,et al.  Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis. , 2005, The Journal of allergy and clinical immunology.

[108]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[109]  D. Metcalfe,et al.  Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. , 2004, Blood.

[110]  D. Gilliland,et al.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.

[111]  David H. Miller,et al.  A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[112]  Jonathan E. Schmitz,et al.  Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* , 2002, The Journal of Biological Chemistry.

[113]  P. Schmid‐Grendelmeier,et al.  High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. , 2002, The Journal of allergy and clinical immunology.

[114]  A. Iwama,et al.  Essential and Instructive Roles of GATA Factors in Eosinophil Development , 2002, The Journal of experimental medicine.

[115]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[116]  T. Graf,et al.  Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.

[117]  Lin Ying Liu,et al.  Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. , 2002, Journal of immunology.

[118]  L. Sturla,et al.  Impairment of the Golgi GDP-l-Fucose Transport and Unresponsiveness to Fucose Replacement Therapy in LAD II Patients , 2001, Pediatric Research.

[119]  J. Erjefält,et al.  Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.

[120]  B. Bochner Road signs guiding leukocytes along the inflammation superhighway. , 2000, The Journal of allergy and clinical immunology.

[121]  F. Symon,et al.  Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. , 2000, Blood.

[122]  Jianzhi Zhang,et al.  Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[124]  C. Barlow,et al.  CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis (Review). , 1998, International journal of molecular medicine.

[125]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[126]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[127]  R. Steigbigel,et al.  Eosinophilia in patients infected with human immunodeficiency virus. , 1996, The Journal of infectious diseases.

[128]  F. Symon,et al.  Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent , 1994, The Journal of experimental medicine.

[129]  M. Blaser,et al.  Disseminated coccidioidomycosis associated with extreme eosinophilia. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[130]  H. Rosenberg,et al.  Neutrophil-specific granule deficiency includes eosinophils. , 1993, Blood.

[131]  D. Wong,et al.  Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. , 1993, Journal of immunology.

[132]  P. Spessotto,et al.  Eosinophil peroxidase deficiency: morphological and immunocytochemical studies of the eosinophil-specific granules. , 1992, Blood.

[133]  G. Gleich,et al.  Sequestration of eosinophil major basic protein in human mast cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[134]  D. Boggs,et al.  Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration , 1987, American journal of hematology.

[135]  T. Springer,et al.  Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. , 1987, Annual review of medicine.

[136]  U. Blumenthal,et al.  Eosinophilia and resistance to Schistosoma haematobium in man , 1985, Parasite immunology.

[137]  H. Sampson,et al.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. , 1985, The New England journal of medicine.

[138]  G. Gleich,et al.  Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. , 1984, Laboratory investigation; a journal of technical methods and pathology.